Recent studies question the benefits of the good
cholesterol (H.D.L.) on heart disease

April 10, 2004
ASHInfo News

Results from a recent study published in
the Journal of the American Medical
Association give doubt to the protective
benefit of high level of High Density
Lipoproteins (H.D.L) on heart disease.  
In this study, H.D.L. levels were shown to
play no role in plaque growth. Only the
Low Density Lipoprotein (L.D.L.) levels
mattered.

When L.D.L. levels dropped, plaque growth slowed. That means,
concludes Dr. Nissen – author of the study, that the benefit of
lowering L.D.L. is the same whether H.D.L. levels are high or low.
more...

FDA issues suicidal warning on antidepressants

March 25, 2004
ASHInfo News

This Monday, the Food and Drug
Administration (FDA) issues a Public Health
Advisory linking antidepressants to
increased suicidal attempts in affected
patients.This warning extends to most of
the newer antidepressants: Prozac
(fluoxetine), Zoloft (sertraline), Paxil
(paroxetine), Luvox (fluvoxamine), Celexa
(citalopram), Lexapro (escitalopram),
Wellbutrin (bupropion), Effexor
(venlafaxine), Serzone (nefazodone), and
Remeron (mirtazapine).

The FDA requests the drug makers to include a warning in their
labeling that recommends close observation of patients, both
adults and pediatrics, for worsening of depression or emergence of
suicidal ideation. more...

The Bush administration pushes stronger state
monitoring of prescription drug use

March 18, 2004
ASHInfo News

The escalating abusing trend of sedatives, pain
relievers and stimulants worries government
officials.  This trend is characterized by increased
reports of the theft of doctors' prescription pads,
callers to pharmacies who pretend to be
physicians, and nurses who call in prescriptions
for themselves.  

In response, the Bush administration is pushing for stronger state
monitoring of prescription drug use.more...

Copyright © 2004 All materials contained herein are intellectual
properties of the Asian Society of Healthcare Information. Unauthorized
copy or redistribution for commercial purposes is prohibited and will be
penalized under law. Permission for academic uses may be obtained by
contacting ASHInfo at generalinfo@ashinfo.net


Disclaimer: The information provided herein is not intended as a
substitute for your healthcare experts’ judgment, skill, and knowledge.
Drug information may not cover all possible uses, directions, precautions,
warnings, drug interactions, allergic reactions, or adverse effects. All
materials may be subject to time sensitivity.

Site Map | About Us | Contact Us | Become a Member | Privacy Notice


Copyright © 2004 ASHInfo, LLC
All rights reserved.